Tugay Aksakalli

Tugay Aksakalli

Auto-generated profile, based on publicly available information

Tugay Aksakalli

Department of Urology, University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in International Journal of Intelligent Systems
Verified
Journal Article
Open access
PDF file
UKUgur Kilic
Ugur Kilic
IAIşıl Karabey Aksakallı
Işıl Karabey Aksakallı
GOGulsah Tumuklu Ozyer
Gulsah Tumuklu Ozyer
TATugay Aksakalli
Tugay Aksakalli
BÖBarış Özyer
Barış Özyer
SASenol Adanur
Senol Adanur
In diagnosing kidney stone disease, clinical specialists often apply medical imaging techniques such as CT, X‐Ray and US. Among these imaging techniques, X‐Ray is frequently chosen as the primary examination method in emergency services due to its low cost, accessibility, and low radiation levels. However, interpreting the X‐Ray images by inexperienced specialists can be challenging due to the low image quality and the presence of noise. In this study, we propose a computer‐aided diagnosis system based on deep neural networks to assist clinical specialists in detecting kidney stones using Direct Urinary System X‐Ray (DUSX) images. Firstly, in consultation with clinical specialists, we created a new dataset composed of 630 DUSX images and presented it publicly. We also defined preprocessing steps that incorporate image enhancement techniques such as GF, LoG, BF, HE, CLAHE, and CBC to enable deep neural networks to perceive the images more clearly. With these techniques, we considered the noise reduction in the DUSX images and enhanced the poor quality, especially in terms of contrast. For each preprocessing step, we created models to detect kidney stones using YOLOv4 and Mask R‐CNN architectures, which are common CNN‐based object detectors. We examined the effects of the preprocessing steps on these models. To the best of our knowledge, the combination of BF and CLAHE which is called CBC in this study, has not been applied before in the literature to enhance DUSX images. In addition, this study is the first in its field in which the YOLOv4 and Mask R‐CNN architectures have been used for the detection of kidney stones. The experimental results demonstrated the most accurate method is the YOLOv4 model, which includes the CBC preprocessing step, as the result model. This model shows that the accuracy rate, precision, recall, and F1‐score were found as 96.1%, 99.3% 96.5%, and 97.9% respectively in the test set. According to these performance metrics, we expect that the proposed model will help to reduce the unnecessary radiation exposure and associated medical costs that come with CT scans.

25 December 2022 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
TATugay Aksakallı
Tugay Aksakallı
BKBakytbek Kozubaev
Bakytbek Kozubaev
TYTurgut Yapanoğlu
Turgut Yapanoğlu
AUAdem Utlu
Adem Utlu
FAFatih Alper
Fatih Alper
NBNuman Bulut
Numan Bulut
Background: Bladder paraganglioma is a neuroendocrine tumor that accounts for less than 0.1% of all bladder tumors. Symptoms caused by catecholamine release such as hypertension, palpitation, syncope, and macroscopic hematuria are the most common findings. Treatment modalities include transurethral resection, and partial or total cystectomy. Case presentation: A 38-year-old Turkish female patient was examined for hematuria that had been persisting for 6 months. Among the clinical findings, only hematuria was present. Absence of adrenergic symptoms such as hypertension, palpitations, and syncope at the first presentation made it difficult to consider bladder paraganglioma in the differential diagnosis. Therefore, cystoscopy and transurethral resection were performed with the thought of urothelial cancer. Findings such as hypertension and bradycardia that developed during diagnostic transurethral resection suggested that it might be bladder paraganglioma. After the radiological evaluation and endocrinological preparation, the patient underwent partial cystectomy. Conclusion: The rarity of cases having been reported in the literature leads to uncertainties in the management of bladder paraganglioma. Adrenergic symptoms developing during transurethral resection should suggest paraganglioma in the differential diagnosis. A multidisciplinary approach and medical treatment are mandatory to prevent life-threatening complications such as hypertensive crisis, vascular collapse, and multiple-organ system failure. We aimed to report the clinical presentation that includes only macroscopic hematuria mimicking urothelial cancer and to emphasize the multidisciplinary approach in the treatment.

12 March 2025 in BMC Urology
Verified
Journal Article
Open access
PDF file
TATugay Aksakalli
Tugay Aksakalli
AUAdem Utlu
Adem Utlu
FCFeyzullah Celik
Feyzullah Celik
ACAhmet Emre Cinislioglu
Ahmet Emre Cinislioglu
SDSaban Oguz Demirdogen
Saban Oguz Demirdogen
IKIbrahim Karabulut
Ibrahim Karabulut
Intravesical BCG treatment is the most frequently preferred adjuvant treatment option with its effective results in non-muscle invasive bladder tumors. Despite effective results, systemic and local side effects can be observed and can be one of the main reasons for treatment discontinuation. In this study we aimed to identify clinical factors predicting BCG-related side effects during intravesical BCG therapy in patients with non-muscle invasive bladder cancer. Demographic and clinical data of patients who received intravesical adjuvant BCG therapy for non-muscle invasive bladder tumor were obtained from patient records. Data on side effects following intravesical BCG therapy and clinical approaches were collected. After creating the patient sample, binary logistic regression analysis was performed to identify parameters and independent risk factors predicting BCG-related side effects, and to evaluate data related to the clinical management of BCG-related side effects. Among the 276 patients included in the study, 23(8.3%) developed BCG-related local and systemic side effects. The mean IPSS(13.5 ± 2.9 vs. 17.6 ± 1.7) and mean tumor size(2.5 ± 0.9 vs. 3.6 ± 1.0 cm)were significantly higher in the group with BCG-related side effects(p < 0.001). The rate of CIS was significantly higher in the group with BCG-related side effects(21.7% vs. 3.9%,p = 0.004). Local side effects included cystitis symptoms in 18(78.2%) patients and epididymo-orchitis in 2(8.6%) patients. Systemic side effects included malaise and fever below 38.5 °C in 4(17.3%) patients, and fever above 38.5 °C lasting longer than 48 h in 2(8.6%) patients. Logistic regression analysis identified IPSS, tumor size, and the presence of CIS as independent risk factors. High IPSS, large tumor size, and the presence of CIS were significant predictors of side effects during intravesical BCG therapy. Clinicians can ensure more effective use of BCG by preventing treatment discontinuation through approaches such as the use of quinolones and dose reduction in patients with these factors.

1 January 2022 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
TATugay Aksakallı
Tugay Aksakallı
ACAhmet Emre Cinislioğlu
Ahmet Emre Cinislioğlu
YAYılmaz Aksoy
Yılmaz Aksoy
Primary monosymptomatic nocturnal enuresis is a common clinical condition in childhood and affects the psychosocial development of the child. The management of this clinical condition, which includes the preschool and adolescence period, is very important for child development. Diagnostic evaluation should be performed in terms of diabetes mellitus, diabetes inspidus, neurogenic bladder, spinal anomalies, and congenital urogenital system anomalies. Treatment modalities in primary monosymptomatic nocturnal enuresis include enuretic alarm therapy, behavioral therapy, and pharmacological treatments such as desmopressin, tricyclic antidepressants, and anticholinergics. There are also experimental treatments such as percutaneous nerve stimulation, acupuncture, and manual therapy. In this study, we examined randomized controlled studies in the literature that included alarm monotherapy and combined therapy. We aimed to present the efficacy, advantages, and disadvantages of combined treatment with the results of the studies. Cite this article as: Aksakallı T, Cinislioğlu AE, Aksoy Y. The efficacy of combined alarm therapy versus alarm monotherapy in the treatment of monosymptomatic nocturnal enuresis: A review of current literature. Eurasian J Med., 2022;54(Suppl. 1):S164-S167.

10 February 2024 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
TATugay Aksakalli
Tugay Aksakalli
IAIsil Karabey Aksakalli
Isil Karabey Aksakalli
ACAhmet Emre Cinislioglu
Ahmet Emre Cinislioglu
AUAdem Utlu
Adem Utlu
SDSaban Oguz Demirdogen
Saban Oguz Demirdogen
IKIbrahim Karabulut
Ibrahim Karabulut

30 October 2024 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
ACAhmet Emre Cinislioğlu
Ahmet Emre Cinislioğlu
NCNazan Cinislioğlu
Nazan Cinislioğlu
MÖMetin İsHak Öztürk
Metin İsHak Öztürk
FAFatih Akkaş
Fatih Akkaş
TATugay Aksakallı
Tugay Aksakallı
AKAteş Kadıoğlu
Ateş Kadıoğlu
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.